ResMed (RMD) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $227.20 -0.53%
Revenue Growth %: +6.9%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +6.9%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.58, $0.01 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $411.6 million versus the consensus estimate of $406.29 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Corpay agrees to $100M FTC settlement over marketing practices
- Can global equities keep rising? UBS sees these factors driving upside
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
